Glimepiride Accord Healthcare (Glimepiride)

Glimepiride Accord Healthcare is indicated for the oral management of hyperglycemia in adults with type 2 diabetes mellitus, typically when diet and exercise alone are insufficient.

• Used as monotherapy in patients with newly diagnosed type 2 diabetes who do not achieve glycemic targets with non‑pharmacologic measures.
• Added to other oral antidiabetic agents (e.g., metformin) when combination therapy is required.
• Considered when a rapid reduction in fasting plasma glucose is desired.
• Prescribed for patients with preserved pancreatic beta‑cell function.
• Utilized as part of an individualized diabetes care plan under physician supervision.

Glimepiride Accord Healthcare may cause a range of adverse effects; they are categorized by frequency and clinical significance.

Common

• Mild hypoglycemia (especially if meals are missed)
• Nausea or abdominal discomfort
• Headache
• Dizziness

Serious

• Severe hypoglycemia leading to loss of consciousness
• Allergic reactions such as rash, itching, or swelling
• Hematologic abnormalities (e.g., leukopenia, thrombocytopenia)

Before initiating glimepiride therapy, clinicians should evaluate several patient-specific factors and monitor for potential risks.

• Assess renal and hepatic function; dose adjustment may be required in impairment.
• Verify that the patient has adequate pancreatic beta‑cell reserve.
• Use caution in elderly patients due to increased hypoglycemia risk.
• Avoid use during pregnancy; safety data are insufficient.
• Counsel patients on recognizing and managing hypoglycemia.
• Review concomitant medications that may potentiate glucose‑lowering effects.

Glimepiride can interact with other drugs, altering its glucose‑lowering action or increasing adverse event risk.

Avoid

• Concurrent use with other sulfonylureas or insulin, which may cause additive hypoglycemia.
• Strong CYP2C9 inhibitors (e.g., fluconazole, amiodarone) that increase glimepiride plasma levels.
• Discontinuous alcohol intake, which can potentiate hypoglycemic episodes.

Use with caution

• Beta‑blockers, which may mask hypoglycemia symptoms.
• Thiazide diuretics, which can affect glucose tolerance.